This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

WILLIAM R. BEAVERS, M.D.; BENJAMIN G. COVINO, Ph.D.

AMA Arch Surg. 1957;75(5):776-779.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The chief hazard in the use of hypothermic anesthesia continues to be the occurrence of ventricular fibrillation. In order to avoid this complication, the level of hypothermia induced during surgical procedures is usually restricted to rectal temperatures above 28 C (82.4 F). The advantages of hypothermia in surgery increase, however, in proportion to the lowering of temperature. In an effort to control fibrillation at low temperatures, the antiarrhythmic effects of many pharmacological agents have been investigated,^1,2 but few have been found wholly satisfactory.

Aminoacetic acid U. S. P. (Glycine), an amino acid, has been reported to suppress cyclopropane-epinephrine-induced arrhythmias.³ In a previous study,⁴ intravenous aminoacetic acid was shown to be easily administered, safe, and well tolerated by hypothermic animals. The present investigation was initiated, therefore, to evaluate the use of intravenous aminoacetic acid as a means of preventing ventricular fibrillation during hypothermia, with and without the added . . . [Full Text PDF of this Article]

Author Affiliations
Dallas, Texas; Seattle

From the Arctic Aeromedical Laboratory, Department of Physiology, APO 731, Seattle. Dr. Beavers formerly Captain, Medical Corp, United States Air Force.

Footnotes
Submitted for publication April 4, 1957.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?